Skip To Main Content
Yingyun Cai on Muck Rack

Yingyun Cai

As seen in: Science Magazine, Cell Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingyun

Contact Yingyun, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults

|
By Simon Perrin, Hai-Liang Zhang, Johnathon Liddicoat, Yingyun Cai
| Science Magazine Verified
Editor’s summary Monoclonal antibody (mAb) therapies for SARS-CoV-2 were an essential component of the treatment toolbox for the first few years of the pandemic. Unfortunately, contemporary SARS-CoV-2 variants have evolved to escape these previously approved mAb therapies, leading to suspension of their use. For most individuals, this is acceptable, because we have our own antibodies generated by vaccination and prior infection.
Open in Who Shared Issue with article?

A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures

|
By Yingyun Cai, Julie Dyall, Shuiqing Yu, Janie Liang
| MDPI
clear search menu Search for Articles: Logical OperatorOperator Submit to this Journal Review for this Journal Edit a Special Issue Article Menu /ajax/scifeed/subscribe Need Help? Support Find support for a specific problem on the support section of our website. Get Support Feedback Please let us know what you think of our products and services. Give Feedback Information Our dedicated information section provides allows you to learn more about MDPI.
Open in Who Shared Issue with article?

A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region

|
By Yingyun Cai, Masaharu Iwasaki
| American Society for Microbiology (ASM)
Research Article | Therapeutics and Prevention Yingyun Cai, Masaharu Iwasaki, Daisuke Motooka, David X. Liu, Shuiqing Yu, Kurt Cooper, Randy Hart, Ricky Adams, Tracey Burdette, Elena N. Postnikova, Jonathan Kurtz, Marisa St. Claire, Chengjin Ye, Jens H. Kuhn, Luis Martínez-Sobrido, Juan Carlos de la Torre Michael S. Diamond, Editor DOI: 10.1128/mBio.00186-20 ABSTRACT Lassa virus (LASV) poses a significant public health problem within the regions of Lassa fever endemicity in Western Africa.
Open in Who Shared Issue with article?
See all 6 articles